<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) cream containing 0.6 mg/ml of bovine SOD was prepared </plain></SENT>
<SENT sid="1" pm="."><plain>It was applied locally onto the skin and mucosal lesions caused by progressive systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (<z:chebi fb="17" ids="53277">PSS</z:chebi>), <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease, <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> and burns </plain></SENT>
<SENT sid="2" pm="."><plain>The lesions and symptoms were rapidly improved in many cases after its administration, even when the symptoms were stabilized for several weeks before the treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Although the trial was open-labelled, the topical application of SOD was concluded to be effective for these conditions </plain></SENT>
</text></document>